Pharmacological Reversal of Histone Methylation Presensitizes Pancreatic Cancer Cells to Nucleoside Drugs: In Vitro Optimization and Novel Nanoparticle Delivery Studies-Reference-Cited by-同舟云学术

Pharmacological Reversal of Histone Methylation Presensitizes Pancreatic Cancer Cells to Nucleoside Drugs: In Vitro Optimization and Novel Nanoparticle Delivery Studies

Published:2013-08-06 Issue:8 Volume:8 Page:e71196
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hung Sau Wai,Mody Hardik,Marrache Sean,Bhutia Yangzom D.,Davis Franklin,Cho Jong Hyun,Zastre Jason,Dhar Shanta,Chu Chung K.,Govindarajan Rajgopal

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Mechanisms of polycomb gene silencing: knowns and unknowns;JA Simon;Nat Rev Mol Cell Bio,2009

2. Crea F, Fornaro L, Bocci G, Sun L, Farrar WL, et al.. (2012) EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis. Cancer Metast Rev: 1–9.

3. EZH2 is essential for glioblastoma cancer stem cell maintenance;ML Suvà;Cancer Res,2009

4. Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression;B Bao;Cancer Res,2012

5. Polycomb genes and cancer: Time for clinical application?;F Crea;CRC Cr Rev Oncol-Hem,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of N6-methyladenosine RNA modification in regulation of SARS-CoV-2 infection and virus-host interactions;Biomedicine & Pharmacotherapy;2024-04

2. Epigenetic Drugs as Modulators of Tumor Immunogenicity and Host Immune Response;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. Epigenetic Alterations in Pancreatic Cancer;Epigenetics and Human Health;2023

4. Epigenetic Regulation Towards Acquired Drug Resistance in Cancer;Subcellular Biochemistry;2022

5. Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas;Cancers;2021-09-16